Genoray Co. Ltd (122310) — Capital Reinvestment Ratio

Latest as of December 2025: 0.03x

Genoray Co. Ltd (122310) has a Capital Reinvestment Ratio of 0.03x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩4.78 Billion) in capital expenditures (₩126.47 Million). See 122310 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.03x
Capex / Operating Cash Flow

Operating Cash Flow

₩4.78 Billion
KRW

Capital Expenditures

₩126.47 Million
KRW

Data as of

Dec 2025
Most recent filing

Genoray Co. Ltd Capital Reinvestment Ratio (2015–2025)

This chart tracks Genoray Co. Ltd's Capital Reinvestment Ratio across 11 annual periods.

Annual Capital Reinvestment Ratio for Genoray Co. Ltd (2015–2025)

Year-by-year Capital Reinvestment Ratio for Genoray Co. Ltd from 2015 to 2025. For live market cap and broader valuation context, see market value of Genoray Co. Ltd.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2025 0.27x ₩5.26 Billion ₩1.40 Billion ▼ -43.7%
2024 0.47x ₩13.27 Billion ₩6.29 Billion ▼ -80.4%
2023 2.42x ₩3.55 Billion ₩8.60 Billion ▲ +288.1%
2022 0.62x ₩14.84 Billion ₩9.25 Billion ▲ +79.7%
2021 0.35x ₩15.38 Billion ₩5.33 Billion ▲ +421.2%
2020 0.07x ₩8.51 Billion ₩566.06 Million ▼ -29.2%
2019 0.09x ₩10.65 Billion ₩1.00 Billion ▼ -53.2%
2018 0.20x ₩6.89 Billion ₩1.38 Billion ▲ +8.0%
2017 0.19x ₩4.47 Billion ₩830.19 Million ▼ -59.1%
2016 0.45x ₩3.47 Billion ₩1.58 Billion ▼ -60.2%
2015 1.14x ₩2.10 Billion ₩2.40 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow